Contraceptives Market Report 2026
Global Outlook – By Product (Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices), By Age Group (15-24 Years, 25-34 Years, 35-44 Years, 44 Years), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels) – Market Size, Trends, Strategies, and Forecast to 2030
Contraceptives Market Overview
• Contraceptives market size has reached to $29.74 billion in 2025 • Expected to grow to $43.09 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: Population Growth Fueling The Contraceptive Market Addressing Global Population Rise Through Contraceptive Solution • Market Trend: Revolutionizing Access Perrigo's Opill The First Non-Prescription Progestin-Only Daily Oral Contraceptive In The Us • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Contraceptives Market?
Contraceptive refers to a method or act that involves the use of a variety of medicines, sexual behaviors, chemicals, medications, or surgical procedures to intentionally prevent conception. Contraceptive is any method, measure, or action designed to keep a woman from getting pregnant. The main product types of contraceptives include oral contraceptive pills, topical contraceptives, injectables, diaphragms, vaginal rings, condoms, contraceptive sponges, subdermal implants, and intra-uterine devices. Oral contraceptive pills are contraceptive tablets or birth control pills to prevent pregnancy. It includes hormones that prevent eggs from being released from the ovaries. The contraceptives are used by a wide range of age groups, ranging from 15–24 years, 25–34 years, 35–44 years, and over 44 years. The contraceptives are distributed by clinics, hospitals, independent pharmacies, and other locations.
What Is The Contraceptives Market Size and Share 2026?
The contraceptives market size has grown strongly in recent years. It will grow from $29.74 billion in 2025 to $32.02 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to government-led family planning initiatives, increased availability of oral contraceptive pills, rising urban female workforce participation, public health campaigns on population control, expansion of hospital and clinic-based contraceptive services.What Is The Contraceptives Market Growth Forecast?
The contraceptives market size is expected to see strong growth in the next few years. It will grow to $43.09 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growth in non-hormonal and male contraceptive innovation, rising penetration of online pharmacies, increasing reproductive health awareness among adolescents, technological advancements in implantable devices, supportive regulatory approvals for novel contraceptives. Major trends in the forecast period include rising adoption of long-acting reversible contraceptives, increasing preference for non-hormonal contraceptive options, growing demand for female-controlled contraceptive methods, expansion of over-the-counter and self-administered products, increasing focus on adolescent and young adult contraceptive awareness.
Global Contraceptives Market Segmentation
1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices 2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years 3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels Subsegments: 1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills 2) By Topical Contraceptives: Transdermal Patches, Gel Applications 3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables 4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms 5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings 6) By Condoms: Male Condoms, Female Condoms 7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges 8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants 9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDsWhat Is The Driver Of The Contraceptives Market?
The global rise in population rates is expected to propel the growth of the contraceptive market in the coming years. Population refers to the overall number of individuals, species, or people living in a certain geographic region, country, or the entire planet. Contraceptives play a significant part in decreasing population by allowing couples and individuals to regulate and plan their household size and child spacing. For instance, in December 2024, according to the United States Census Bureau, a US-based federal agency, the U.S. population reached 340.1 million as of July 1, 2024, reflecting a 0.98% increase from 336.8 million in 2023 the highest annual growth rate recorded. Therefore, the global rise in population rates is driving the contraceptive industry.Key Players In The Global Contraceptives Market
Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Contraceptives Market Trends and Insights
Major companies operating in the contraceptives market are focusing on innovative products, such as Opill, progestin-only daily oral contraceptives, to better meet the needs of their existing consumers. Opill progestin-only daily oral contraceptives, often known as the mini-pill, are a kind of birth control pill that includes just progestin, a synthetic version of the hormone progesterone. For instance, in July 2023, Perrigo Company plc, an Ireland-based manufacturing company of over-the-counter pharmaceuticals, announced U. S. Food and Drug Administration (FDA) approval for Opill progestin-only daily oral contraceptives. Opill is the very first birth control pill available without a prescription in the United States. Opill can significantly improve women's availability of contraceptives and is a genuine testament to Perrigo's constant dedication to delivering meaningful solutions that improve people's lives.What Are Latest Mergers And Acquisitions In The Contraceptives Market?
In March 2024, Insud Pharma, a Spain-based company that manufactures pharmaceuticals acquired oral and injectable contraceptives, from Viatris for an undisclosed amount. With this acquisition, Insud Pharma aims to enhance its product portfolio in women's health by integrating Viatris' oral and injectable contraceptives, thereby expanding its market presence and providing a broader range of reproductive healthcare solutions to meet the growing demand for contraceptive options. Viatris is a US-based company that manufactures pharmaceuticals.
Regional Insights
North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Contraceptives Market?
The contraceptive market consists of sales of combined pills, Contraceptive patch, and female condoms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Contraceptives Market Report 2026?
The contraceptives market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptives industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Contraceptives Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $32.02 billion |
| Revenue Forecast In 2030 | $43.09 billion |
| Growth Rate | CAGR of 7.7% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product, Age Group, Distribution Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |